Open Insider Trading Activity for Cytomx Therapeutics, Inc. Chief Financial Officer Ogden Christopher
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting CTMX | 2026-06-17 | 2026-06-15 | Cytomx Therapeutics, Inc. | Ogden Christopher | Chief Financial Officer | Sell | 1 | 1,624 | $3.05 | $4,953.20 | 0.55% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting CTMX | 2026-03-19 | 2026-03-17 | Cytomx Therapeutics, Inc. | Ogden Christopher | Chief Financial Officer | Sell | 1 | 19,323 | $6.42 | $124,053.66 | 6.11% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting CTMX | 2024-08-22 | 2024-08-20 | Cytomx Therapeutics, Inc. | Ogden Christopher | Chief Financial Officer | Sell | 1 | 1,984 | $1.23 | $2,440.32 | 1.80% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting CTMX | 2024-03-21 | 2024-03-19 | Cytomx Therapeutics, Inc. | Ogden Christopher | SVP, Finance and Accounting | Sell | 1 | 2,971 | $2.09 | $6,209.39 | 3.35% | View Filing |